Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
256,606,920
-
Total 13F shares
-
239,982,115
-
Share change
-
+2,697,680
-
Total reported value
-
$20,645,253,416
-
Put/Call ratio
-
81%
-
Price per share
-
$86.02
-
Number of holders
-
473
-
Value change
-
+$255,018,558
-
Number of buys
-
237
-
Number of sells
-
218
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q2 2016
As of 30 Jun 2016,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
473 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
239,982,115 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Capital World Investors, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, STATE STREET CORP, AMERIPRISE FINANCIAL INC, Clearbridge Investments, LLC, and BlackRock Institutional Trust Company, N.A..
This page lists
474
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.